Shima Rahmati

898 total citations
30 papers, 708 citations indexed

About

Shima Rahmati is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shima Rahmati has authored 30 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Shima Rahmati's work include Extracellular vesicles in disease (9 papers), Tissue Engineering and Regenerative Medicine (8 papers) and MicroRNA in disease regulation (8 papers). Shima Rahmati is often cited by papers focused on Extracellular vesicles in disease (9 papers), Tissue Engineering and Regenerative Medicine (8 papers) and MicroRNA in disease regulation (8 papers). Shima Rahmati collaborates with scholars based in Iran, United States and Germany. Shima Rahmati's co-authors include Lynn Zechiedrich, Leila Rezakhani, Amy L. Davidson, Shirley Yang, Richard W. Deibler, Morteza Alizadeh, Mozafar Khazaei, Ali Shojaeian, Samira Asgharzade and Razieh Heidari and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Molecular Microbiology.

In The Last Decade

Shima Rahmati

29 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shima Rahmati Iran 13 420 160 118 87 82 30 708
Jun Lei China 21 576 1.4× 106 0.7× 74 0.6× 72 0.8× 72 0.9× 76 1.0k
Stina Lindberg Sweden 7 239 0.6× 146 0.9× 62 0.5× 52 0.6× 45 0.5× 10 641
Hamed Afkhami Iran 20 400 1.0× 90 0.6× 65 0.6× 99 1.1× 109 1.3× 84 1.1k
Tiwei Fu China 17 301 0.7× 67 0.4× 72 0.6× 115 1.3× 67 0.8× 32 671
Abul Kalam Azad United States 21 724 1.7× 92 0.6× 32 0.3× 213 2.4× 103 1.3× 61 1.4k
Bo Shi China 22 635 1.5× 130 0.8× 25 0.2× 123 1.4× 61 0.7× 77 1.4k
Danqing Lei China 11 271 0.6× 37 0.2× 82 0.7× 65 0.7× 39 0.5× 15 514
Sisi He China 12 350 0.8× 90 0.6× 36 0.3× 28 0.3× 38 0.5× 19 675
Takashi Suematsu Japan 13 419 1.0× 35 0.2× 154 1.3× 57 0.7× 127 1.5× 28 985
Jieying Liu China 21 527 1.3× 169 1.1× 68 0.6× 127 1.5× 132 1.6× 45 1.2k

Countries citing papers authored by Shima Rahmati

Since Specialization
Citations

This map shows the geographic impact of Shima Rahmati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shima Rahmati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shima Rahmati more than expected).

Fields of papers citing papers by Shima Rahmati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shima Rahmati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shima Rahmati. The network helps show where Shima Rahmati may publish in the future.

Co-authorship network of co-authors of Shima Rahmati

This figure shows the co-authorship network connecting the top 25 collaborators of Shima Rahmati. A scholar is included among the top collaborators of Shima Rahmati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shima Rahmati. Shima Rahmati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jalili, Ali, et al.. (2024). Decellularized skin pretreatment by monophosphoryl lipid A and lactobacillus casei supernatant accelerate skin recellularization. Molecular Biology Reports. 51(1). 675–675. 2 indexed citations
2.
Rahmati, Shima, et al.. (2024). Exosome-loaded decellularized tissue: Opening a new window for regenerative medicine. Journal of Tissue Viability. 33(2). 332–344. 5 indexed citations
3.
Rahmati, Shima, et al.. (2023). Prospects of plant-derived exosome-like nanocarriers in oncology and tissue engineering. Human Cell. 37(1). 121–138. 19 indexed citations
4.
Rahmati, Shima, et al.. (2023). Exosome-loaded scaffolds for regenerative medicine in hard tissues. Tissue and Cell. 82. 102102–102102. 31 indexed citations
5.
Rezakhani, Leila, Mitra Darbandi, Zahra Khorrami, Shima Rahmati, & Fatemeh Khosravi Shadmani. (2023). Mortality and disability-adjusted life years for smoking-attributed cancers from 1990 to 2019 in the north Africa and middle east countries: a systematic analysis for the global burden of disease study 2019. BMC Cancer. 23(1). 80–80. 12 indexed citations
6.
Rahmati, Shima, et al.. (2022). Undifferentiated embryonal sarcoma of the liver in a 9-year-old girl. SHILAP Revista de lepidopterología. 25(1). 59–61.
7.
Rahmati, Shima, et al.. (2022). Comparison of human acellular amniotic membranes with acellular amniotic membranes pretreated with MPLA for repair of fascia in rats. Cell and Tissue Banking. 24(2). 495–501. 4 indexed citations
8.
Rezakhani, Leila, et al.. (2022). Exosomes: special nano-therapeutic carrier for cancers, overview on anticancer drugs. Medical Oncology. 40(1). 31–31. 15 indexed citations
9.
Rezakhani, Leila, Shima Rahmati, Sorayya Ghasemi, Morteza Alizadeh, & Akram Alizadeh. (2022). A comparative study of the effects of crab derived exosomes and doxorubicin in 2 & 3-dimensional in vivo models of breast cancer. Chemistry and Physics of Lipids. 243. 105179–105179. 24 indexed citations
10.
Khazaei, Mozafar, Mohammad Rasool Khazaei, Morteza Alizadeh, Shima Rahmati, & Leila Rezakhani. (2021). Functional survey of decellularized tissues transplantation for infertile females. Cell and Tissue Banking. 23(3). 407–415. 9 indexed citations
11.
Rahmati, Shima, et al.. (2021). Oleuropein reduces cisplatin resistance in ovarian cancer by targeting apoptotic pathway regulators. Life Sciences. 278. 119525–119525. 28 indexed citations
12.
Rahmati, Shima, et al.. (2020). The Effect of Encapsulated Umbilical Cord-derived Mesenchymal Stem Cells in PRPCryogel on Regeneration of Grade-II Burn Wounds. Regenerative Engineering and Translational Medicine. 8(1). 75–85. 8 indexed citations
13.
Rahmati, Shima, et al.. (2020). Does survivin overexpression enhance the efficiency of fibroblast cell-based wound therapy?. Molecular Biology Reports. 47(8). 5851–5864. 3 indexed citations
14.
Rezakhani, Leila, et al.. (2020). Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises. Chemistry and Physics of Lipids. 234. 105009–105009. 70 indexed citations
15.
Rahmati, Shima, et al.. (2019). An overview of current knowledge in biological functions and potential theragnostic applications of exosomes. Chemistry and Physics of Lipids. 226. 104836–104836. 58 indexed citations
16.
Roshani, Daem, et al.. (2017). Association of p53 codon 72 Arg>Pro polymorphism and risk of cancer in Iranian population: A systematic review and meta-analysis. Medical Journal of the Islamic Republic of Iran. 31(1). 896–902. 2 indexed citations
17.
Nikpour, Parvaneh, et al.. (2014). EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot study. Medical Oncology. 31(5). 955–955. 12 indexed citations
18.
Rahmati, Shima, Shirley Yang, Amy L. Davidson, & Lynn Zechiedrich. (2002). Control of the AcrAB multidrug efflux pump by quorum‐sensing regulator SdiA. Molecular Microbiology. 43(3). 677–685. 156 indexed citations
19.
Moreno, Nancy, et al.. (2001). Teaming Up with Scientists.. Science and Children. 39(1). 42–45. 7 indexed citations
20.
Deibler, Richard W., Shima Rahmati, & Lynn Zechiedrich. (2001). Topoisomerase IV, alone, unknots DNA in E. coli. Genes & Development. 15(6). 748–761. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026